Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Management of venous thromboembolism--controversies and the future.

Keeling D, Alikhan R.

Br J Haematol. 2013 Jun;161(6):755-63. doi: 10.1111/bjh.12306. Epub 2013 Mar 26. Review.

PMID:
23531017
2.

NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing.

Howard LS, Hughes RJ.

Thorax. 2013 Apr;68(4):391-3. doi: 10.1136/thoraxjnl-2012-202376. Epub 2012 Dec 12.

PMID:
23234857
3.

Controversies in venous thromboembolism--2015.

Keeling D, Klok FA, Le Gal G.

Blood Rev. 2016 Jan;30(1):27-33. doi: 10.1016/j.blre.2015.07.003. Epub 2015 Jul 17. Review.

PMID:
26239706
4.

Recurrent venous thromboembolism.

Galioto NJ, Danley DL, Van Maanen RJ.

Am Fam Physician. 2011 Feb 1;83(3):293-300. Review.

5.

Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.

Barginear MF, Gralla RJ, Bradley TP, Ali SS, Shapira I, Greben C, Nier-Shoulson N, Akerman M, Lesser M, Budman DR.

Support Care Cancer. 2012 Nov;20(11):2865-72. doi: 10.1007/s00520-012-1413-z. Epub 2012 Mar 16.

PMID:
22421738
6.

Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.

Kovacs MJ, Kahn SR, Wells PS, Anderson DA, Chagnon I, LE Gal G, Solymoss S, Crowther M, Perrier A, Ramsay T, Betancourt MT, White RH, Vickars L, Rodger MA.

J Thromb Haemost. 2010 Sep;8(9):1926-32. doi: 10.1111/j.1538-7836.2010.03958.x.

7.

Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.

Barsam SJ, Patel R, Arya R.

Br J Haematol. 2013 Jun;161(6):764-77. doi: 10.1111/bjh.12314. Epub 2013 Apr 5. Review.

PMID:
23560605
8.

Optimal duration of anticoagulation in patients with venous thromboembolism.

Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesavento R.

Indian J Med Res. 2011 Jul;134:15-21. Review.

9.

Diagnosis and initial treatment of venous thromboembolism in patients with cancer.

Streiff MB.

J Clin Oncol. 2009 Oct 10;27(29):4889-94. doi: 10.1200/JCO.2009.23.5788. Epub 2009 Sep 8. Review.

PMID:
19738109
10.

[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].

Zawilska K, Bała MM, Błędowski P, Chmielewski DW, Dobrowolski Z, Frączek M, Frołow M, Gajewski P, Guzik T, Jaeschke R, Korman T, Kotarski J, Kozubski W, Krawczyk M, Kruszewski W, Kulikowski J, Kutaj-Wąsikowska H, Mayzner-Zawadzka E, Mrozikiewicz PM, Musiał J, Niżankowski R, Pasierski T, Poręba R, Tomkowski W, Torbicki A, Undas A, Urbanek T, Wojtukiewicz MZ, Woroń J, Wroński J; Working Group fom the Anticoagulation and Thrombolytic ACCP Conference.

Pol Arch Med Wewn. 2012;122 Suppl 2:3-74. Polish.

11.

Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.

Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P; Groupe Francophone Thrombose et Cancer (GFTC).

Thromb Res. 2010 Apr;125 Suppl 2:S108-16. doi: 10.1016/S0049-3848(10)70027-X. Review.

PMID:
20433988
12.

Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.

Imberti D, Agnelli G, Ageno W, Moia M, Palareti G, Pistelli R, Rossi R, Verso M; MASTER Investigators.

Haematologica. 2008 Feb;93(2):273-8. doi: 10.3324/haematol.11458. Epub 2008 Jan 26.

13.

Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.

Kearon C.

J Thromb Thrombolysis. 2011 Apr;31(3):295-300. doi: 10.1007/s11239-011-0573-x. Review.

PMID:
21331558
14.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
15.

Venous thrombo-embolic disease.

Shakoor H, Santacruz JF, Dweik RA.

Compr Ther. 2009 Spring;35(1):24-36. Review.

PMID:
19351102
16.

Venous thromboembolism: a clinical review.

Osinbowale O, Ali L, Chi YW.

Postgrad Med. 2010 Mar;122(2):54-65. doi: 10.3810/pgm.2010.03.2122. Review.

PMID:
20203456
17.

Treatment and secondary prevention of venous thromboembolism in cancer.

Coleman R, MacCallum P.

Br J Cancer. 2010 Apr 13;102 Suppl 1:S17-23. doi: 10.1038/sj.bjc.6605601. Review.

18.

[The optimal duration of anticoagulant treatment following pulmonary embolism].

Couturaud F.

Rev Mal Respir. 2011 Dec;28(10):1265-77. doi: 10.1016/j.rmr.2011.04.017. Epub 2011 Nov 3. Review. French.

PMID:
22152935
19.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
20.

Venous thromboembolism overview.

Battinelli EM, Murphy DL, Connors JM.

Hematol Oncol Clin North Am. 2012 Apr;26(2):345-67, ix. doi: 10.1016/j.hoc.2012.02.010. Review.

PMID:
22463831

Supplemental Content

Support Center